Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C van Rossum

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
BMJ Paediatrics Open|April 12, 2018
Perspectives of adolescents on decision making about participation in a biobank study: a pilot studyPetronella Grootens-Wiegers, Eline G Visser, Annemarie M C van Rossum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapyPieter L A Fraaij, Gwenda Verweel, Annemarie M C van Rossum, et al.
AIDS (London, England)|September 16, 2022
Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara AfricaHylke Waalewijn, Kim Stol, Linda van der Knaap, et al.
AIDS (London, England)|July 12, 2013
Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012Sophie Cohen, Colette Smit, Annemarie M C van Rossum, et al.
The Pediatric Infectious Disease Journal|January 15, 2016
Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis: An International Survey and Review of GuidelinesWendy van Herk, Salhab el Helou, Jan Janota, et al.
The Pediatric Infectious Disease Journal|February 24, 2018
Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected ChildrenDiane E T Bastiaans, Sibyl P M Geelen, Eline G Visser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in ChildrenPatrick M Meyer Sauteur, Selina Krautter, Lilliam Ambroggio, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2019
Diagnosis of <i>Mycoplasma pneumoniae</i> Pneumonia with Measurement of Specific Antibody-Secreting CellsPatrick M Meyer Sauteur, Michelle Seiler, Johannes Trück, et al.
JAMA Pediatrics|September 4, 2019
Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysisNiek B Achten, Claus Klingenberg, William E Benitz, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
BMJ Paediatrics Open|April 12, 2018
Perspectives of adolescents on decision making about participation in a biobank study: a pilot studyPetronella Grootens-Wiegers, Eline G Visser, Annemarie M C van Rossum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapyPieter L A Fraaij, Gwenda Verweel, Annemarie M C van Rossum, et al.
AIDS (London, England)|September 16, 2022
Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara AfricaHylke Waalewijn, Kim Stol, Linda van der Knaap, et al.
AIDS (London, England)|July 12, 2013
Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012Sophie Cohen, Colette Smit, Annemarie M C van Rossum, et al.
The Pediatric Infectious Disease Journal|January 15, 2016
Variation in Current Management of Term and Late-preterm Neonates at Risk for Early-onset Sepsis: An International Survey and Review of GuidelinesWendy van Herk, Salhab el Helou, Jan Janota, et al.
The Pediatric Infectious Disease Journal|February 24, 2018
Pharmacokinetics, Short-term Safety and Efficacy of the Approved Once-daily Darunavir/Ritonavir Dosing Regimen in HIV-infected ChildrenDiane E T Bastiaans, Sibyl P M Geelen, Eline G Visser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2019
Improved Diagnostics Help to Identify Clinical Features and Biomarkers That Predict Mycoplasma pneumoniae Community-acquired Pneumonia in ChildrenPatrick M Meyer Sauteur, Selina Krautter, Lilliam Ambroggio, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2019
Diagnosis of <i>Mycoplasma pneumoniae</i> Pneumonia with Measurement of Specific Antibody-Secreting CellsPatrick M Meyer Sauteur, Michelle Seiler, Johannes Trück, et al.
JAMA Pediatrics|September 4, 2019
Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysisNiek B Achten, Claus Klingenberg, William E Benitz, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected childrenA S Bergshoeff, P L A Fraaij, A M C van Rossum, et al.
Pageof 12